Arrowhead Pharmaceuticals
ARWR · NASDAQ
Bulios Fair Price
$43.14
32.8% downside
Trenutna cena
$64.19
Po podatkih Bulios Fair Price je delnica ARWR trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Arrowhead Pharmaceuticals is a U.S.-based biotechnology company focused on developing innovative therapies targeting genetic diseases. The company is particularly known for its advanced RNA interference (RNAi) technology, which enables the "turning off" or regulation of genes associated with various diseases. Arrowhead Pharmaceuticals focuses on developing drugs for the treatment of rare and chronic conditions, including genetic disorders, viral infections, and cardiovascular diseases, aiming to improve treatment outcomes and the quality of life for patients.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Christopher R. Anzalone
Employees
711
Headquarters
Pasadena
Prihajajoči dogodki
Earnings
Upcoming earnings report